Press Releases

Press Releases

    Date Title View
    07/16/21
    Summary ToggleFortune Names Horizon Therapeutics One of the 2021 Best Workplaces for Millennials™
    PDF Version
    07/08/21
    Summary ToggleHorizon Therapeutics plc to Release Second-Quarter 2021 Financial Results and Host Webcast on Aug. 4, 2021
    PDF Version
    06/30/21
    Summary ToggleHorizon Therapeutics plc to Host Virtual R&D Day on Sept. 29, 2021
    PDF Version
    06/29/21
    Summary ToggleHorizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating HZN-7734 for the Treatment of Systemic Lupus Erythematosus
    PDF Version
    06/28/21
    Summary ToggleGail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Community to FOCUS on Thyroid Eye Disease
    PDF Version
    06/21/21
    Summary ToggleArrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
    PDF Version
    06/18/21
    Summary ToggleHorizon Therapeutics plc Announces Multiple Presentations on Neuromyelitis Optica Spectrum Disorder (NMOSD) at the 7th Congress of the European Academy of Neurology (EAN)
    PDF Version
    06/17/21
    Summary ToggleHorizon Therapeutics plc Announces Purchase of Manufacturing Facility to Support Growth of On-Market Rare Disease and Pipeline Biologics
    PDF Version
    06/02/21
    Summary ToggleHorizon Therapeutics plc Presents New Data on Robust Pipeline at EULAR European Congress of Rheumatology
    PDF Version
    05/27/21
    Summary ToggleHorizon Therapeutics plc Initiates ADVANCE Trial Evaluating KRYSTEXXA® (pegloticase injection) with Methotrexate for People Who Previously Developed Anti-Drug Antibodies on KRYSTEXXA Monotherapy
    PDF Version
    Displaying 1 - 10 of 590 results